Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04087174
Title A Multi-centre Study to Assess the Safety, Tolerability, and Pharmacokinetics of Capivasertib (AZD5363) in Combination With Novel Agents in Patients With Metastatic Prostate Cancer
Recruitment Completed
Gender male
Phase Phase I
Variant Requirements No
Sponsors AstraZeneca
Indications

prostate cancer

Therapies

Abiraterone + Capivasertib

Capivasertib + Enzalutamide

Age Groups: adult | senior
Covered Countries USA | ESP


No variant requirements are available.